Tokyo, Japan

Kunikazu Furuhata


Average Co-Inventor Count = 8.9

ph-index = 2

Forward Citations = 35(Granted Patents)


Location History:

  • Tokyo, JP (1990)
  • Namerikawa, JP (1996)

Company Filing History:


Years Active: 1990-1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kunikazu Furuhata: Innovator in Pharmaceutical Chemistry

Introduction

Kunikazu Furuhata is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications. With a total of 2 patents to his name, Furuhata's work is recognized for its potential impact on medical treatments.

Latest Patents

Furuhata's latest patents include innovative compounds such as a 1,2-benzoisoxazole derivative or its salt, which showcases his expertise in creating novel chemical entities. Additionally, he has developed a brain-protecting agent, specifically a piperazine derivative or its salt, which is aimed at curing cerebro-vascular diseases and addressing post-cerebro-vascular conditions. This piperazine derivative is represented by a specific formula, highlighting its unique chemical structure and potential therapeutic benefits.

Career Highlights

Throughout his career, Kunikazu Furuhata has been associated with Toyama Chemical Co., Ltd., where he has contributed to various research initiatives. His work has focused on the synthesis and application of chemical compounds that can lead to advancements in medical treatments. Furuhata's dedication to innovation in pharmaceutical chemistry has positioned him as a key figure in his field.

Collaborations

Furuhata has collaborated with esteemed colleagues such as Kenji Takeda and Joji Nakano. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.

Conclusion

Kunikazu Furuhata's contributions to pharmaceutical chemistry through his patents and collaborations reflect his commitment to innovation and improving healthcare outcomes. His work continues to inspire advancements in the treatment of cerebro-vascular diseases and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…